An Infection-Responsive KCoF3@Fe-HA Hydrogel for Localized Co/Fe Dual Fenton-like Therapy of MRSA-Infected Wounds
ACS Applied Bio Materials · 2026
DOI: 10.1021/acsabm.6c01413 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Yutong Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Capital Medical University, Beijing100069, P.R. China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Hydrogels, Anti-Bacterial Agents, Biocompatible Materials. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Methicillin-resistant Staphylococcus aureus (MRSA)-infected wounds remain difficult to treat because bacterial persistence, inflammation, antimicrobial resistance, and poorly controlled local toxicity can jointly impair tissue repair. Herein, we report an infection-responsive KCoF3@Fe-HA hydrogel that integrates potassium cobalt fluoride (KCoF3) with an Fe3+-crosslinked hyaluronic acid (HA) network for localized Co/Fe dual Fenton-like antibacterial therapy. Notably, the use of KCoF3 in antibacterial wound dressing systems has not yet been reported. In this design, KCoF3 serves as a confined Co reservoir, while the Fe-HA network provides catalytic Fe species and a biodegradable hydrogel matrix. The introduction of Co-mediated Fenton-like activity may broaden the effective catalytic pH range and compensate for the limited activity of Fe-based Fenton-like systems under infection-relevant weakly acidic conditions. Meanwhile, the HA network provides infection responsiveness, allowing weak acidity and bacteria-associated hyaluronidase to promote localized network relaxation and degradation. Together with the reservoir-like KCoF3 structure, this design enables sustained Fe/Co release around infected tissues, helping to maintain local antibacterial activity while reducing burst Co exposure and unnecessary metal leakage. KCoF3@Fe-HA showed stronger Fenton-like catalytic activity than single-metal hydrogel systems. The hydrogel exhibited broad-spectrum antibacterial activity against MRSA, Staphylococcus aureus (S. aureus), and Escherichia coli (E. coli) and effectively reduced bacterial burden in an MRSA-infected full-thickness wound model. Wounds treated with KCoF3@Fe-HA closed faster and showed weaker inflammatory signals, greater collagen deposition, and increased angiogenesis. Cytocompatibility, hemolysis, blood analysis, and major-organ histology supported its preliminary biosafety. This work provides a localized Co/Fe Fenton-like dressing strategy for antibiotic-free MRSA-infected wound healing, presenting KCoF3 as a confined Co reservoir integrated with an infection-responsive HA hydrogel network.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Capital Medical University, Beijing100069, P.R. China.
- School of Basic Medical Sciences, Capital Medical University, Beijing100069, P.R. China.
- Core Facility Center, Capital Medical University, Beijing100069, P.R. China.
Förderung
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Liu, Y., Li, Z., Li, J., Han, W., Li, S., Liu, Q., Zhao, H., Wang, H., & Gu, W. (2026). An Infection-Responsive KCoF3@Fe-HA Hydrogel for Localized Co/Fe Dual Fenton-like Therapy of MRSA-Infected Wounds. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c01413
Vancouver
Liu Y, Li Z, Li J, Han W, Li S, Liu Q, et al. An Infection-Responsive KCoF3@Fe-HA Hydrogel for Localized Co/Fe Dual Fenton-like Therapy of MRSA-Infected Wounds. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c01413
BibTeX
@article{Liu2026,
author = {Liu, Yutong and Li, Zhonghan and Li, Jinzhan and Han, Weifan and Li, Sizhang and Liu, Qianshuo and Zhao, Huanying and Wang, Hao and Gu, Wei},
title = {An Infection-Responsive KCoF3@Fe-HA Hydrogel for Localized Co/Fe Dual Fenton-like Therapy of MRSA-Infected Wounds},
journal = {ACS Applied Bio Materials},
year = {2026},
doi = {10.1021/acsabm.6c01413}
}
EUVIMED